6/17
Inconc.
Late treatment study
et al., Annals of Oncology, 31:10, 1386-1396, doi:10.1016/j.annonc.2020.06.007 (Peer Reviewed)
COVID-19 in patients with lung cancer
Analysis of hospitalized lung cancer patients with 35 of 48 taking HC Q, mortality OR 1.03, p = 0.99.
death, ↑2.2%, p=0.99
(odds ratio converted to relative risk)
(odds ratio converted to relative risk)